MMI raises $125 million in Series D led by BioStar, joined by S3 Ventures
Medical Microinstruments (MMI), a surgical robotics developer, raised $125 million in a Series D financing. BioStar Capital led the round; S3 Ventures joined as a new investor alongside Angelini Ventures and an undisclosed strategic investor. Proceeds target commercial expansion in the U.S. and other key markets for MM